Basics of Compounding for Cough
Download in electronic PDF format for $75
Abstract: Cough is a symptom of a number of pathologic conditions, including infections and pulmonary, cardiac, and gastrointestinal disorders. It also can be caused by medication. While numerous prescription and nonprescription treatments for cough are available, these are not suitable for all patients in all situations. Extemporaneous compounding allows preparation of customized formulations that contains a variety of difference components in a dosage form convenient for the patient. Formulas and methods are provided for several frequently prescribed compounds. The initial step in treating cough is eliminating exposure to any irritant or discontinuing any medication that might be causing the cough. Depending on the cause of the cough, drug therapies include antihistamines (with or without decongestant), intranasal or oral corticosteroids, antibiotics, bronchodilators, topical volatile agents (eg, camphor, menthol, thymol), guaifenesin (antitussive/expectorant), or centrally acting drugs that suppress the cough reflex (codeine sulfate, dextromorphan hydrobromide, hydrocodone bitartrate, hydromorphone hydrochloride).
Related Keywords:
Loyd V. Allen, Jr., PhD, RPh, continuing education, coughing, bronchial secretions, antitussive effects, central suppression, medication side effect, formulation: dextromorphan 30-mg capsules, formulation: terpin hydrate and codeine elixir, formulation: guaifenesin 100 mg/5 mL and promethazine hydrochloride 10 mg/5 mL cough syrup, formulation: dextromorphan hydrobromide 20-mg lollipops with menthol and eucalyptus oil, formulation: hydrocodone 5-mg or hydromorphone 1-mg troches, formulation: codeine sulfate 15-mg suppositories, formulation: dextromorphan 30-mg suppositories, formulation: inhalant volatiles for vaporizers
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Colds and Cough
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 480-483
|
Basics of Compounding for Terrorist Attacks, Part 2
Allen Loyd V Jr
|
Mar/Apr 2003
Pg. 129-134
View Sample |
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H, Szwejkowski Jessica, Houston Alana
|
Sep/Oct 2001
Pg. 401-405
|
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
McElhiney Linda F
|
May/Jun 2009
Pg. 224-229
|
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
|
Mar/Apr 2010
Pg. 105-107
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
|
Nov/Dec 2022
Pg. 516-521
|
Benzonatate 100-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 326
|
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 388-392
|
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
|
Mar/Apr 2010
Pg. 171-173
|
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph, Bennet Daron, Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 95-107
|
Dextromethorphan Hydrobromide 30-mg Troches
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 67
|
Basics of Compounding: Cosmetics for Special Populations and Using Cosmetics as Vehicles
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 102-105
|
The Basics of Compounding: Compounding Special Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 291-294
|
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 504
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Return to Top |